Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer

European Radiology

Volumn 24, Issue 5, 2014, Pages 998-1005

  Yip, Connie ^a,b,d   Goh, Vicky ^a,c   Davies, Andrew ^c   Gossage, James ^c   Mitchell Hay, Rosalind ^c   Hynes, Orla ^c   Maisey, Nick ^c   Ross, Paul ^c   Gaya, Andrew ^c   Landau, David B ^a,c   Cook, Gary J ^a   Griffin, Nyree ^c   Mason, Robert ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Body composition; Neoadjuvant chemotherapy; Oesophageal cancer; Sarcopenia

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FAT FREE MASS; FAT MASS; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SARCOPENIA; SIDE EFFECT; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; BODY COMPOSITION; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; SARCOPENIA;

EID: 84898820718     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3110-4     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Cancer Research UK (2012) Oesophageal cancer survival statistics, Cancer Research UK, London. http://www.cancerresearchuk.org/cancer-info/cancerstats/ types/oesophagus/survival/. Accessed 2 Sept 2013
3. Berger B, Belka C (2009) Evidence-based radiation oncology: oesophagus. Radiother Oncol 92:276-290
4. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755-763 (Pubitemid 28183275)
5. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889-896 (Pubitemid 34496687)
6. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895-901 (Pubitemid 46454567)
7. Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613-618 (Pubitemid 41103905)
8. McClave SA, Snider HL, Spain DA (1999) Preoperative issues in clinical nutrition. Chest 115:64S-70S (Pubitemid 29228261)
9. Prado CM, Baracos VE, McCargar LJ et al (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264-3268 (Pubitemid 46944911)
10. Prado CM, Baracos VE, McCargar LJ et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920-2926
11. Prado CM, Lima IS, Baracos VE et al (2011) An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol 67:93-101
12. Balentine CJ, Enriquez J, Fisher Wet al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832-1837
13. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629-635
14. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15:6973-6979
15. Awad S, Tan BH, Cui H et al (2012) Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31:74-77
16. Bower MR, Martin RC 2nd (2009) Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol 100:82-87
17. Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680-2686 (Pubitemid 24166250)
18. Mapstone NP (2007) Dataset for the histopathological reporting of oesophageal carcinoma, 2nd edn. Royal College of Pathologists, London
19. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R (1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85:115-122 (Pubitemid 28334913)
20. Kvist H, Sjostrom L, Tylen U (1986) Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes 10:53-67 (Pubitemid 16107655)
21. Vehmas T, Kairemo KJ, Taavitsainen MJ (1996) Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 20:570-573 (Pubitemid 26174343)
22. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997-1006
23. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11-18
24. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14:336-341 (Pubitemid 46214766)
25. Moon HG, Ju YT, Jeong CYet al (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918-1922
26. Clark W, Siegel EM, Chen YA et al (2013) Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation. J Am Coll Surg 216:1070-1081
27. Sheetz KH, Zhao L, Holcombe SA et al (2013) Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer. Dis Esophagus 26:716-722